Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2026RSC Medicinal Chemistry

New roxadustat amino acid drug conjugation derivatives: molecular docking, molecular dynamics simulation and in vitro assay

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMarjan SamadiAHAzizollah HabibiLKLeila Karami

Discussion

Loading...

Member takes

Overview

The study designs novel roxadustat drug conjugates to inhibit PHD enzyme activity, suggesting new therapeutic options.

Key Points

  • The aim is to design novel amino acid drug conjugates of roxadustat for the inhibition of the PHD enzyme.
  • Designed and synthesized a series of amino acid drug conjugates of roxadustat.
  • Conducted molecular docking and molecular dynamics simulations.
  • Performed in vitro assays to evaluate the efficacy of the conjugates.
  • The new drug conjugates showed significant inhibition of PHD enzyme activity.
  • Molecular docking results indicated strong binding affinity to the PHD enzyme.
  • In vitro assays demonstrated enhanced efficacy compared to traditional forms of roxadustat.

Cite This Study

Samadi et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf57cfaef96ed7f057888https://doi.org/10.1039/d6md00094k
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Roxadustat Inhibits Osteoclast Differentiation and Function by Disrupting Cell Cycle Exit2026
  2. 2Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice2024 · 10 citations
  3. 3Efficacy and safety of prolyl hydroxylase inhibitors for anemia in chronic kidney disease: a network meta-analysis2026
  4. 4Rapid and Efficient Antibody–Drug Conjugate Design Using Mechanistic Bottom-Up Modeling from In Vitro to Human2026
  5. 5Computational Evaluation of ADMET Properties and Molecular Docking Studies of 1,2,4-oxadiazole Analogs as Potential Inhibitors of Prostate Cancer2025